Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19601086 | 0.89 | FFAR4 (0.36) | LMNASMN1; SMN2MEN1ALDH1A1MAPT | |
| SCHEMBL19601078 | 0.87 | ALDH1A1 (0.31) | LMNAHTTRAB9ASMN1; SMN2TDP1 | |
| SCHEMBL19601117 | 0.83 | ACHE (0.37) | LMNAHTTSMN1; SMN2ALDH1A1KMT2A | |
| SCHEMBL19607239 | 0.81 | L3MBTL1 (0.36) | RAB9ASMN1; SMN2KDM4EMEN1ALDH1A1 | |
| SCHEMBL19601082 | 0.79 | ACHE (0.43) | RAB9A | |
| SCHEMBL19601113 | 0.78 | CYP1A1 (0.35) | LMNAHTTRAB9ASMN1; SMN2KDM4E | |
| SCHEMBL25813690 | 0.75 | PABPC1 (0.44) | LMNAHTTRAB9ASMN1; SMN2TDP1 | |
| SCHEMBL19601098 | 0.74 | ACHE (0.41) | LMNAHTTRAB9ASMN1; SMN2KDM4E | |
| SCHEMBL19601135 | 0.73 | ESR2 (0.36) | LMNAHTTRAB9ASMN1; SMN2TDP1 | |
| SCHEMBL19607400 | 0.72 | HDAC1 (0.34) | HTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10310350-B2 | Organic compound, electrochromic compound, and electrochromic element, optical filter, lens unit, imaging device, and window component having same | CANON KABUSHIKI KAISHA (JP) | 2019-06-04 | — | — | US | disclosed |
| US-20170329195-A1 | ORGANIC COMPOUND, ELECTROCHROMIC COMPOUND, AND ELECTROCHROMIC ELEMENT, OPTICAL FILTER, LENS UNIT, IMAGING DEVICE, AND WINDOW COMPONENT HAVING SAME | CANON KABUSHIKI KAISHA (JP) | 2017-11-16 | — | — | US | disclosed |
| US-20170329195-A1 | ORGANIC COMPOUND, ELECTROCHROMIC COMPOUND, AND ELECTROCHROMIC ELEMENT, OPTICAL FILTER, LENS UNIT, IMAGING DEVICE, AND WINDOW COMPONENT HAVING SAME | CANON KABUSHIKI KAISHA (JP) | 2017-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10310350-B2 | Organic compound, electrochromic compound, and electrochromic element, optical filter, lens unit, imaging device, and window component having same | KCNJ2, KCNH3, KCNN2 | LMNA 845/4885HTT 3915/4885RAB9A 2741/4885 |
| US-20170329195-A1 | ORGANIC COMPOUND, ELECTROCHROMIC COMPOUND, AND ELECTROCHROMIC ELEMENT, OPTICAL FILTER, LENS UNIT, IMAGING DEVICE, AND WINDOW COMPONENT HAVING SAME | KCNJ2, KCNH3, KCNN2 | LMNA 845/4885HTT 3915/4885RAB9A 2741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.